78 related articles for article (PubMed ID: 14612927)
1. Repressions of actin assembly and RhoA localization are involved in inhibition of tumor cell motility by lipophilic ascorbyl phosphate.
Liu JW; Kayasuga A; Nagao N; Masatsuji-Kato E; Tuzuki T; Miwa N
Int J Oncol; 2003 Dec; 23(6):1561-7. PubMed ID: 14612927
[TBL] [Abstract][Full Text] [Related]
2. [Study on the mechanism of inhibition of tumor cell motility by ascorbic acid derivatives].
Liu JW; Wei DZ; Du CB; Miwa N
Shi Yan Sheng Wu Xue Bao; 2002 Jun; 35(2):82-8. PubMed ID: 15344324
[TBL] [Abstract][Full Text] [Related]
3. Antimetastatic and anti-invasive ability of phospho-ascorbyl palmitate through intracellular ascorbate enrichment and the resultant antioxidant action.
Liu JW; Nagao N; Kageyama K; Miwa N
Oncol Res; 1999; 11(10):479-87. PubMed ID: 10850889
[TBL] [Abstract][Full Text] [Related]
4. Anti-metastatic effect of an autooxidation-resistant and lipophilic ascorbic acid derivative through inhibition of tumor invasion.
Liu JW; Nagao N; Kageyama K; Miwa N
Anticancer Res; 2000; 20(1A):113-8. PubMed ID: 10769642
[TBL] [Abstract][Full Text] [Related]
5. Slow-down of age-dependent telomere shortening is executed in human skin keratinocytes by hormesis-like-effects of trace hydrogen peroxide or by anti-oxidative effects of pro-vitamin C in common concurrently with reduction of intracellular oxidative stress.
Yokoo S; Furumoto K; Hiyama E; Miwa N
J Cell Biochem; 2004 Oct; 93(3):588-97. PubMed ID: 15378602
[TBL] [Abstract][Full Text] [Related]
6. Increased importin-beta-dependent nuclear import of the actin modulating protein CapG promotes cell invasion.
De Corte V; Van Impe K; Bruyneel E; Boucherie C; Mareel M; Vandekerckhove J; Gettemans J
J Cell Sci; 2004 Oct; 117(Pt 22):5283-92. PubMed ID: 15454578
[TBL] [Abstract][Full Text] [Related]
7. Cytoprotection of vascular endotheliocytes by phosphorylated ascorbate through suppression of oxidative stress that is generated immediately after post-anoxic reoxygenation or with alkylhydroperoxides.
Saitoh Y; Miwa N
J Cell Biochem; 2004 Nov; 93(4):653-63. PubMed ID: 15389975
[TBL] [Abstract][Full Text] [Related]
8. Antimetastatic effect of a lipophilic ascorbic acid derivative with antioxidation through inhibition of tumor invasion.
Liu J; Zhang X; Yang F; Li T; Wei D; Ren Y
Cancer Chemother Pharmacol; 2006 May; 57(5):584-90. PubMed ID: 16075276
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of BPA degradation by serum as a hydroxyl radical scavenger and an Fe trapping agent in Fenton process.
Sajiki J; Masumizu T
Chemosphere; 2004 Oct; 57(4):241-52. PubMed ID: 15312722
[TBL] [Abstract][Full Text] [Related]
10. Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling.
Zhong WB; Liang YC; Wang CY; Chang TC; Lee WS
Endocr Relat Cancer; 2005 Sep; 12(3):615-29. PubMed ID: 16172195
[TBL] [Abstract][Full Text] [Related]
11. Scavenging of reactive oxygen species by the plant phenols genistein and oleuropein.
Kruk I; Aboul-Enein HY; Michalska T; Lichszteld K; Kładna A
Luminescence; 2005; 20(2):81-9. PubMed ID: 15803505
[TBL] [Abstract][Full Text] [Related]
12. [Serum response factor participates in RhoA-induced endothelial cell F-actin rearrangements].
Han YL; Yu HB; Yan CH; Meng ZM; Zhang XL; Kang J; Li SH; Wang SW
Sheng Li Xue Bao; 2005 Jun; 57(3):295-302. PubMed ID: 15968423
[TBL] [Abstract][Full Text] [Related]
13. RhoA mediates cyclooxygenase-2 signaling to disrupt the formation of adherens junctions and increase cell motility.
Chang YW; Marlin JW; Chance TW; Jakobi R
Cancer Res; 2006 Dec; 66(24):11700-8. PubMed ID: 17178865
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal administration of Y-27632, a specific rho-associated kinase inhibitor, for rat neoplastic meningitis.
Nakagawa H; Yoshioka K; Miyahara E; Fukushima Y; Tamura M; Itoh K
Mol Cancer Res; 2005 Aug; 3(8):425-33. PubMed ID: 16123138
[TBL] [Abstract][Full Text] [Related]
15. The anandamide analog, Met-F-AEA, controls human breast cancer cell migration via the RHOA/RHO kinase signaling pathway.
Laezza C; Pisanti S; Malfitano AM; Bifulco M
Endocr Relat Cancer; 2008 Dec; 15(4):965-74. PubMed ID: 18676619
[TBL] [Abstract][Full Text] [Related]
16. Memo-RhoA-mDia1 signaling controls microtubules, the actin network, and adhesion site formation in migrating cells.
Zaoui K; Honoré S; Isnardon D; Braguer D; Badache A
J Cell Biol; 2008 Nov; 183(3):401-8. PubMed ID: 18955552
[TBL] [Abstract][Full Text] [Related]
17. Roles of p-ERM and Rho-ROCK signaling in lymphocyte polarity and uropod formation.
Lee JH; Katakai T; Hara T; Gonda H; Sugai M; Shimizu A
J Cell Biol; 2004 Oct; 167(2):327-37. PubMed ID: 15504914
[TBL] [Abstract][Full Text] [Related]
18. 2- and 4-Aminobiphenyls induce oxidative DNA damage in human hepatoma (Hep G2) cells via different mechanisms.
Wang SC; Chung JG; Chen CH; Chen SC
Mutat Res; 2006 Jan; 593(1-2):9-21. PubMed ID: 16112689
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species.
Park MJ; Lee JY; Kwak HJ; Park CM; Lee HC; Woo SH; Jin HO; Han CJ; An S; Lee SH; Chung HY; Park IC; Hong SI; Rhee CH
J Cell Biochem; 2005 Aug; 95(5):955-69. PubMed ID: 15962302
[TBL] [Abstract][Full Text] [Related]
20. The role of RhoA in the regulation of cell morphology and motility.
Tkach V; Bock E; Berezin V
Cell Motil Cytoskeleton; 2005 May; 61(1):21-33. PubMed ID: 15776463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
